Sutro Biopharma (NASDAQ: STRO): Pioneering cancer therapeutics via innovative technology
Sutro Biopharma, Inc. (NASDAQ: STRO), headquartered in South San Francisco, CA, is a pioneering biopharmaceutical company founded on April 21, 2003, by James R. Swartz and Sutanto Widjaja. Their core mission revolves around revolutionizing cancer and autoimmune therapeutics through innovative drug discovery, development, and manufacturing.
